New York State Teachers Retirement System Has $39.56 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV)

New York State Teachers Retirement System decreased its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 5.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 166,940 shares of the medical research company’s stock after selling 9,518 shares during the quarter. New York State Teachers Retirement System owned approximately 0.09% of IQVIA worth $39,560,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Wealth Enhancement Advisory Services LLC increased its stake in shares of IQVIA by 5.4% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 5,898 shares of the medical research company’s stock valued at $1,492,000 after buying an additional 300 shares during the period. Allspring Global Investments Holdings LLC raised its stake in shares of IQVIA by 3.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 170,451 shares of the medical research company’s stock valued at $43,105,000 after acquiring an additional 5,240 shares during the last quarter. Norden Group LLC acquired a new position in shares of IQVIA during the first quarter worth $703,000. First Trust Direct Indexing L.P. grew its stake in shares of IQVIA by 2.7% in the first quarter. First Trust Direct Indexing L.P. now owns 9,299 shares of the medical research company’s stock worth $2,352,000 after purchasing an additional 243 shares during the last quarter. Finally, American National Bank & Trust Co. VA acquired a new stake in IQVIA in the first quarter valued at $207,000. Institutional investors own 89.62% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Robert W. Baird upped their price target on IQVIA from $251.00 to $256.00 and gave the company a “neutral” rating in a research report on Friday, September 20th. Evercore ISI decreased their target price on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Argus upgraded shares of IQVIA to a “strong-buy” rating in a research report on Wednesday, July 31st. Jefferies Financial Group cut shares of IQVIA from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $266.00 to $242.00 in a research report on Wednesday, July 24th. Finally, Barclays dropped their target price on shares of IQVIA from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Tuesday, October 15th. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $267.27.

Insider Buying and Selling at IQVIA

In related news, insider Eric Sherbet sold 1,300 shares of the company’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total value of $320,229.00. Following the sale, the insider now owns 19,536 shares in the company, valued at $4,812,302.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.60% of the company’s stock.

IQVIA Stock Performance

NYSE IQV opened at $216.04 on Thursday. The company has a market cap of $39.38 billion, a P/E ratio of 28.06, a PEG ratio of 2.09 and a beta of 1.49. The company has a fifty day simple moving average of $235.88 and a 200 day simple moving average of $230.06. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 1.80. IQVIA Holdings Inc. has a 12-month low of $167.42 and a 12-month high of $261.73.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.